Patients with cystic fibrosis (CF) suffer from chronic airway infections with the opportunistic pathogen Pseudomonas aeruginosa (PA), and experience worsening, irreversible lung injury leading to premature death. This injury is mediated by an inflammatory process that results, at least in part, from stimulation of the innate immune system by PA lipid A, the bioactive component of lipopolysaccharide (LPS). Preliminary data indicates that PA responds to the CF lung environment by synthesizing lipid A structures not present in clinical isolates from non- CF PA infections. This project will test the hypothesis that CF-specific lipid A structures promote resistance to innate immune mechanisms such as antimicrobial peptides and result in increased inflammatory responses. Key steps in the synthesis of CF-specific lipid A are hydroxylation, palmitoylation, and the synthesis and transfer of aminoarabinose. Genes encoding the relevant enzymes will be defined, and insertional mutants will be constructed and tested in assays of antimicrobial peptide resistance. Aerosolization of mutant whole bacteria or LPS into the murine airway or incubation in cell culture will be used to test the role of CF-specific lipid A modifications in inflammatory responses. CF-specific lipid A structures will be purified and their biological activity characterized. Finally, outer membrane proteins (OMPs) coordinately regulated with CF-specific lipid A will be identified by proteomic analysis, and the role of such OMPs in antimicrobial peptide resistance will be assayed in insertional mutants. These studies will provide insight into bacterial mechanisms that contribute to CF lung disease, including the role of lipid A modifying enzymes. Such enzymes may provide novel targets for the development of drugs to treat PA lung infections and their inflammatory consequences.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI047938-03
Application #
6608151
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Program Officer
Taylor, Christopher E,
Project Start
2001-03-15
Project End
2006-02-28
Budget Start
2003-03-01
Budget End
2004-02-29
Support Year
3
Fiscal Year
2003
Total Cost
$342,000
Indirect Cost
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Hittle, Lauren E; Powell, Daniel A; Jones, Jace W et al. (2015) Site-specific activity of the acyltransferases HtrB1 and HtrB2 in Pseudomonas aeruginosa lipid A biosynthesis. Pathog Dis 73:ftv053
Thaipisuttikul, Iyarit; Hittle, Lauren E; Chandra, Ramesh et al. (2014) A divergent Pseudomonas aeruginosa palmitoyltransferase essential for cystic fibrosis-specific lipid A. Mol Microbiol 91:158-74
Yoon, Sung Hwan; Huang, Yue; Edgar, J Scott et al. (2012) Surface acoustic wave nebulization facilitating lipid mass spectrometric analysis. Anal Chem 84:6530-7
Damron, F Heath; Davis Jr, Michael R; Withers, T Ryan et al. (2011) Vanadate and triclosan synergistically induce alginate production by Pseudomonas aeruginosa strain PAO1. Mol Microbiol 81:554-70
Moskowitz, Samuel M; Ernst, Robert K (2010) The role of Pseudomonas lipopolysaccharide in cystic fibrosis airway infection. Subcell Biochem 53:241-53
Kalhorn, Thomas F; Kiavand, Anahita; Cohen, Ilana E et al. (2009) A sensitive liquid chromatography/mass spectrometry-based assay for quantitation of amino-containing moieties in lipid A. Rapid Commun Mass Spectrom 23:433-42
Miao, Edward A; Ernst, Robert K; Dors, Monica et al. (2008) Pseudomonas aeruginosa activates caspase 1 through Ipaf. Proc Natl Acad Sci U S A 105:2562-7
Jones, Jace W; Shaffer, Scott A; Ernst, Robert K et al. (2008) Determination of pyrophosphorylated forms of lipid A in Gram-negative bacteria using a multivaried mass spectrometric approach. Proc Natl Acad Sci U S A 105:12742-7
D'Argenio, David A; Wu, Manhong; Hoffman, Lucas R et al. (2007) Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol 64:512-33
Ernst, Robert K; Moskowitz, Samuel M; Emerson, Julia C et al. (2007) Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis. J Infect Dis 196:1088-92

Showing the most recent 10 out of 18 publications